Peacock
Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; Phasianinae; Pavo,
Latin Name:
Pavo cristatus
Tested tissues: PBMC,
Data set information
| Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
|---|---|---|---|---|---|---|
| Vthunter_0056 | 2021.04 | iDrop | PBMC | Normal | 9248 | Link |
| Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
|---|---|---|
|
Venezuelan equine encephalitis virus |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; |
|
Adeno-associated virus - 8 |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; |
|
Adeno-associated virus 9 |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; |
|
Dengue virus |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; PBMC-B cells : 34.25% ; PBMC-Macrophage : 5.97% ; PBMC-Red blood cell : 3.43% ; PBMC-Platelets : 0.99% ; PBMC-T cells : 0.91% ; PBMC-Macrophage : 7.46% ; PBMC-Red blood cell : 0.36% ; PBMC-T cells : 0.11% ; PBMC-Neutrophil : 0.00% ; PBMC-B cells : 3.42% ; PBMC-Macrophage : 1.49% ; PBMC-Platelets : 1.19% ; PBMC-Red blood cell : 0.78% ; PBMC-T cells : 0.23% ; PBMC-T cells : 0.23% ; PBMC-Red blood cell : 0.12% ; PBMC-B cells : 0.00% ; |
|
Sindbis virus |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; |
|
Classical swine fever virus |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; |
|
Adeno-associated virus - 3 |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; |
|
Adeno-associated virus - 2 |
PBMC-Macrophage : 100.00% ; PBMC-T cells : 99.09% ; PBMC-B cells : 97.95% ; PBMC-NK : 94.41% ; PBMC-Red blood cell : 76.93% ; PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; PBMC-Macrophage : 20.90% ; PBMC-B cells : 5.48% ; PBMC-T cells : 3.98% ; PBMC-Platelets : 3.98% ; PBMC-Neutrophil : 3.92% ; |
|
Simian rotavirus A strain RRV |
PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; PBMC-Macrophage : 95.52% ; PBMC-B cells : 66.44% ; PBMC-T cells : 60.30% ; PBMC-NK : 51.75% ; PBMC-Red blood cell : 44.44% ; PBMC-Platelets : 72.96% ; PBMC-Red blood cell : 39.87% ; PBMC-Macrophage : 29.85% ; PBMC-NK : 17.48% ; PBMC-T cells : 14.22% ; PBMC-Platelets : 57.06% ; PBMC-Red blood cell : 26.97% ; PBMC-Macrophage : 13.43% ; PBMC-B cells : 10.27% ; PBMC-NK : 9.09% ; PBMC-Macrophage : 37.31% ; PBMC-Platelets : 26.64% ; PBMC-Neutrophil : 9.80% ; PBMC-Red blood cell : 9.64% ; PBMC-NK : 9.09% ; |
|
Equid alphaherpesvirus 1 | |
|
Human betaherpesvirus 5 |
PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; PBMC-Platelets : 72.96% ; PBMC-Red blood cell : 39.87% ; PBMC-Macrophage : 29.85% ; PBMC-NK : 17.48% ; PBMC-T cells : 14.22% ; PBMC-Macrophage : 37.31% ; PBMC-Platelets : 26.64% ; PBMC-Neutrophil : 9.80% ; PBMC-Red blood cell : 9.64% ; PBMC-NK : 9.09% ; PBMC-Platelets : 0.20% ; PBMC-Red blood cell : 0.14% ; PBMC-T cells : 0.11% ; PBMC-Neutrophil : 0.00% ; |
|
Human metapneumovirus |
PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; |
|
Hepacivirus C |
PBMC-Macrophage : 98.51% ; PBMC-B cells : 43.84% ; PBMC-NK : 33.57% ; PBMC-T cells : 28.21% ; PBMC-Neutrophil : 19.61% ; PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-B cells : 2.74% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 1.22% ; PBMC-Macrophage : 5.97% ; PBMC-T cells : 3.19% ; PBMC-NK : 2.10% ; PBMC-Red blood cell : 1.16% ; PBMC-B cells : 0.68% ; PBMC-Macrophage : 1.49% ; PBMC-Red blood cell : 0.09% ; PBMC-T cells : 0.57% ; PBMC-Red blood cell : 0.08% ; PBMC-Neutrophil : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-T cells : 0.23% ; PBMC-Red blood cell : 0.12% ; PBMC-B cells : 0.00% ; PBMC-NK : 0.00% ; PBMC-Macrophage : 0.00% ; PBMC-Platelets : 0.20% ; PBMC-Red blood cell : 0.14% ; PBMC-T cells : 0.11% ; |
|
Lassa mammarenavirus |
PBMC-Macrophage : 98.51% ; PBMC-NK : 42.66% ; PBMC-T cells : 26.17% ; PBMC-Neutrophil : 25.49% ; PBMC-B cells : 21.23% ; PBMC-B cells : 34.25% ; PBMC-Macrophage : 5.97% ; PBMC-Red blood cell : 3.43% ; PBMC-Platelets : 0.99% ; PBMC-T cells : 0.91% ; PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-T cells : 2.62% ; PBMC-NK : 1.40% ; PBMC-B cells : 1.37% ; PBMC-Macrophage : 7.46% ; PBMC-Red blood cell : 0.36% ; PBMC-T cells : 0.11% ; PBMC-Neutrophil : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Mammalian orthoreovirus |
PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; |
|
Human parvovirus B19 |
PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; |
|
Echovirus E1 | |
|
Foot-and-mouth disease virus |
PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; PBMC-Platelets : 72.96% ; PBMC-Red blood cell : 39.87% ; PBMC-Macrophage : 29.85% ; PBMC-NK : 17.48% ; PBMC-T cells : 14.22% ; PBMC-Macrophage : 37.31% ; PBMC-Platelets : 26.64% ; PBMC-Neutrophil : 9.80% ; PBMC-Red blood cell : 9.64% ; PBMC-NK : 9.09% ; PBMC-Macrophage : 1.49% ; PBMC-NK : 1.40% ; PBMC-T cells : 0.46% ; PBMC-Red blood cell : 0.26% ; PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.27% ; |
|
Human gammaherpesvirus 4 |
PBMC-Macrophage : 98.51% ; PBMC-Platelets : 65.41% ; PBMC-Neutrophil : 47.06% ; PBMC-NK : 36.36% ; PBMC-T cells : 35.27% ; |
|
Echovirus E8 | |
|
Human rotavirus strain WA | |
|
Influenza A virus |
PBMC-Macrophage : 95.52% ; PBMC-Neutrophil : 9.80% ; PBMC-B cells : 3.42% ; PBMC-T cells : 3.07% ; PBMC-Red blood cell : 2.88% ; PBMC-Macrophage : 16.42% ; PBMC-B cells : 12.33% ; PBMC-T cells : 8.65% ; PBMC-Neutrophil : 3.92% ; PBMC-Red blood cell : 3.60% ; PBMC-B cells : 0.68% ; PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.26% ; PBMC-T cells : 0.11% ; PBMC-Platelets : 0.20% ; PBMC-Red blood cell : 0.14% ; PBMC-T cells : 0.11% ; |
|
Human immunodeficiency virus 2 | |
|
Human immunodeficiency virus 1 |
PBMC-Macrophage : 92.54% ; PBMC-NK : 9.79% ; PBMC-T cells : 3.87% ; PBMC-Red blood cell : 3.01% ; PBMC-B cells : 2.74% ; PBMC-Macrophage : 92.54% ; PBMC-B cells : 71.92% ; PBMC-NK : 56.64% ; PBMC-T cells : 54.27% ; PBMC-Red blood cell : 31.04% ; PBMC-T cells : 16.95% ; PBMC-Macrophage : 8.96% ; PBMC-Red blood cell : 5.37% ; PBMC-NK : 2.10% ; PBMC-Neutrophil : 1.96% ; |
|
Feline immunodeficiency virus | |
|
Simian immunodeficiency virus | |
|
Ebola virus |
PBMC-Macrophage : 85.07% ; PBMC-Red blood cell : 5.78% ; PBMC-NK : 2.10% ; PBMC-Neutrophil : 1.96% ; PBMC-T cells : 1.71% ; PBMC-Macrophage : 52.24% ; PBMC-B cells : 12.33% ; PBMC-T cells : 8.19% ; PBMC-Neutrophil : 5.88% ; PBMC-Red blood cell : 5.43% ; PBMC-B cells : 34.25% ; PBMC-Macrophage : 5.97% ; PBMC-Red blood cell : 3.43% ; PBMC-Platelets : 0.99% ; PBMC-T cells : 0.91% ; PBMC-Macrophage : 7.46% ; PBMC-Red blood cell : 0.36% ; PBMC-T cells : 0.11% ; PBMC-Neutrophil : 0.00% ; |
|
Marburg marburgvirus |
PBMC-Macrophage : 85.07% ; PBMC-Red blood cell : 5.78% ; PBMC-NK : 2.10% ; PBMC-Neutrophil : 1.96% ; PBMC-T cells : 1.71% ; PBMC-B cells : 34.25% ; PBMC-Macrophage : 5.97% ; PBMC-Red blood cell : 3.43% ; PBMC-Platelets : 0.99% ; PBMC-T cells : 0.91% ; PBMC-Macrophage : 7.46% ; PBMC-Red blood cell : 0.36% ; PBMC-T cells : 0.11% ; |
|
Human gammaherpesvirus 8 | |
|
Hantaan orthohantavirus |
PBMC-Platelets : 72.96% ; PBMC-Red blood cell : 39.87% ; PBMC-Macrophage : 29.85% ; PBMC-NK : 17.48% ; PBMC-T cells : 14.22% ; |
|
Coxsackievirus A9 |
PBMC-Platelets : 72.96% ; PBMC-Red blood cell : 39.87% ; PBMC-Macrophage : 29.85% ; PBMC-NK : 17.48% ; PBMC-T cells : 14.22% ; PBMC-Macrophage : 37.31% ; PBMC-Platelets : 26.64% ; PBMC-Neutrophil : 9.80% ; PBMC-Red blood cell : 9.64% ; PBMC-NK : 9.09% ; PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.27% ; PBMC-T cells : 0.00% ; |
|
West Nile virus | |
|
Human parechovirus 1 | |
|
Echovirus E6 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Enterovirus D68 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Coxsackievirus B5 | |
|
Human enterovirus 70 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Echovirus E29 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Echovirus E13 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Coxsackievirus B3 | |
|
Echovirus E7 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Coxsackievirus B1 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; PBMC-Macrophage : 37.31% ; PBMC-Platelets : 26.64% ; PBMC-Neutrophil : 9.80% ; PBMC-Red blood cell : 9.64% ; PBMC-NK : 9.09% ; PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.27% ; PBMC-Red blood cell : 0.09% ; PBMC-B cells : 0.00% ; PBMC-NK : 0.00% ; PBMC-Macrophage : 0.00% ; |
|
Echovirus E33 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Echovirus E20 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Coxsackievirus A21 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Echovirus E21 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Echovirus E12 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Echovirus E11 |
PBMC-Macrophage : 62.69% ; PBMC-Neutrophil : 21.57% ; PBMC-Platelets : 18.49% ; PBMC-Red blood cell : 7.83% ; PBMC-NK : 4.20% ; |
|
Bovine leukemia virus |
PBMC-Macrophage : 58.21% ; PBMC-Neutrophil : 27.45% ; PBMC-NK : 25.87% ; PBMC-B cells : 20.55% ; PBMC-T cells : 19.80% ; |
|
Enterovirus A71 | |
|
Coxsackievirus A16 |
PBMC-Macrophage : 52.24% ; PBMC-Neutrophil : 1.96% ; PBMC-T cells : 0.80% ; PBMC-B cells : 0.68% ; PBMC-Red blood cell : 0.65% ; |
|
Human mastadenovirus C |
PBMC-Macrophage : 49.25% ; PBMC-Neutrophil : 5.88% ; PBMC-Red blood cell : 1.07% ; PBMC-T cells : 0.23% ; PBMC-Platelets : 0.20% ; PBMC-Macrophage : 37.31% ; PBMC-Platelets : 26.64% ; PBMC-Neutrophil : 9.80% ; PBMC-Red blood cell : 9.64% ; PBMC-NK : 9.09% ; PBMC-Red blood cell : 0.09% ; |
|
Chikungunya virus |
PBMC-Macrophage : 44.78% ; PBMC-B cells : 6.85% ; PBMC-T cells : 5.23% ; PBMC-NK : 2.80% ; PBMC-Platelets : 2.58% ; |
|
Human alphaherpesvirus 1 |
PBMC-Macrophage : 37.31% ; PBMC-Platelets : 26.64% ; PBMC-Neutrophil : 9.80% ; PBMC-Red blood cell : 9.64% ; PBMC-NK : 9.09% ; PBMC-Macrophage : 1.49% ; PBMC-NK : 1.40% ; PBMC-T cells : 0.46% ; PBMC-Red blood cell : 0.26% ; PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.27% ; PBMC-Neutrophil : 0.00% ; PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.08% ; |
|
Human alphaherpesvirus 3 |
PBMC-Macrophage : 35.82% ; PBMC-NK : 17.48% ; PBMC-T cells : 15.93% ; PBMC-B cells : 15.75% ; PBMC-Neutrophil : 9.80% ; |
|
Varicella Zoster Virus |
PBMC-Macrophage : 35.82% ; PBMC-NK : 17.48% ; PBMC-T cells : 15.93% ; PBMC-B cells : 15.75% ; PBMC-Neutrophil : 9.80% ; |
|
Polytropic murine leukemia virus |
PBMC-Macrophage : 34.33% ; PBMC-B cells : 13.01% ; PBMC-Neutrophil : 7.84% ; PBMC-T cells : 4.55% ; PBMC-NK : 4.20% ; |
|
Xenotropic murine leukemia virus |
PBMC-Macrophage : 34.33% ; PBMC-B cells : 13.01% ; PBMC-Neutrophil : 7.84% ; PBMC-T cells : 4.55% ; PBMC-NK : 4.20% ; |
|
Hepatovirus A |
PBMC-B cells : 34.25% ; PBMC-Macrophage : 5.97% ; PBMC-Red blood cell : 3.43% ; PBMC-Platelets : 0.99% ; PBMC-T cells : 0.91% ; |
|
Japanese encephalitis virus |
PBMC-Platelets : 31.21% ; PBMC-Red blood cell : 9.23% ; PBMC-Macrophage : 8.96% ; PBMC-T cells : 6.71% ; PBMC-B cells : 3.42% ; |
|
Human papillomavirus type 16 | |
|
Porcine reproductive and respiratory syndrome virus |
PBMC-Macrophage : 25.37% ; PBMC-B cells : 19.18% ; PBMC-NK : 12.59% ; PBMC-T cells : 3.87% ; PBMC-Red blood cell : 2.08% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
PBMC-Platelets : 20.28% ; PBMC-Macrophage : 8.96% ; PBMC-Red blood cell : 6.01% ; PBMC-T cells : 3.98% ; PBMC-NK : 3.50% ; PBMC-Macrophage : 5.97% ; PBMC-T cells : 3.19% ; PBMC-NK : 2.10% ; PBMC-Red blood cell : 1.16% ; PBMC-B cells : 0.68% ; PBMC-Red blood cell : 0.04% ; PBMC-Macrophage : 0.00% ; |
|
JC polyomavirus |
PBMC-Platelets : 19.48% ; PBMC-Macrophage : 7.46% ; PBMC-Red blood cell : 5.47% ; PBMC-B cells : 4.11% ; PBMC-T cells : 2.84% ; |
|
Lymphocytic choriomeningitis mammarenavirus | |
|
Feline panleukopenia virus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-B cells : 2.74% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 1.22% ; |
|
Latino mammarenavirus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-T cells : 2.62% ; PBMC-NK : 1.40% ; PBMC-B cells : 1.37% ; |
|
Canine parvovirus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-B cells : 2.74% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 1.22% ; |
|
Machupo mammarenavirus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-B cells : 2.74% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 1.22% ; |
|
Mouse mammary tumor virus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-B cells : 2.74% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 1.22% ; |
|
Argentinian mammarenavirus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-B cells : 2.74% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 1.22% ; |
|
Oliveros mammarenavirus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-T cells : 2.62% ; PBMC-NK : 1.40% ; PBMC-B cells : 1.37% ; |
|
Guanarito mammarenavirus |
PBMC-Macrophage : 19.40% ; PBMC-Neutrophil : 3.92% ; PBMC-B cells : 2.74% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 1.22% ; |
|
Human betaherpesvirus 7 |
PBMC-T cells : 16.95% ; PBMC-Macrophage : 8.96% ; PBMC-Red blood cell : 5.37% ; PBMC-NK : 2.10% ; PBMC-Neutrophil : 1.96% ; |
|
Vesicular stomatitis virus |
PBMC-Macrophage : 16.42% ; PBMC-B cells : 12.33% ; PBMC-T cells : 8.65% ; PBMC-Neutrophil : 3.92% ; PBMC-Red blood cell : 3.60% ; |
|
Human mastadenovirus B | |
|
Rabies lyssavirus |
PBMC-T cells : 10.92% ; PBMC-Red blood cell : 3.54% ; PBMC-NK : 2.10% ; PBMC-Neutrophil : 1.96% ; PBMC-Platelets : 0.40% ; |
|
Coxsackievirus A10 |
PBMC-T cells : 9.10% ; PBMC-Macrophage : 4.48% ; PBMC-B cells : 2.05% ; PBMC-Red blood cell : 2.05% ; PBMC-Platelets : 0.80% ; |
|
Respiratory syncytial virus |
PBMC-NK : 7.69% ; PBMC-T cells : 3.64% ; PBMC-B cells : 0.68% ; PBMC-Red blood cell : 0.65% ; PBMC-Platelets : 0.40% ; |
|
Human betaherpesvirus 6B |
PBMC-B cells : 7.53% ; PBMC-Macrophage : 7.46% ; PBMC-Neutrophil : 5.88% ; PBMC-T cells : 5.12% ; PBMC-Red blood cell : 1.76% ; |
|
Amphotropic murine leukemia virus |
PBMC-Macrophage : 7.46% ; PBMC-B cells : 5.48% ; PBMC-T cells : 2.39% ; PBMC-NK : 2.10% ; PBMC-Neutrophil : 1.96% ; |
|
Feline leukemia virus strain B/lambda-B1 | |
|
Rubella virus |
PBMC-Macrophage : 7.46% ; PBMC-Red blood cell : 5.39% ; PBMC-Platelets : 5.37% ; PBMC-T cells : 3.87% ; PBMC-NK : 3.50% ; |
|
Gibbon ape leukemia virus | |
|
Zika virus |
PBMC-Macrophage : 7.46% ; PBMC-Red blood cell : 0.36% ; PBMC-T cells : 0.11% ; PBMC-Neutrophil : 0.00% ; |
|
Middle East respiratory syndrome-related coronavirus |
PBMC-Macrophage : 5.97% ; PBMC-Neutrophil : 1.96% ; PBMC-Red blood cell : 0.16% ; PBMC-Platelets : 0.00% ; PBMC-T cells : 0.00% ; |
|
Feline leukemia virus strain C/FA27 |
PBMC-Macrophage : 5.97% ; PBMC-B cells : 2.74% ; PBMC-T cells : 2.28% ; PBMC-Red blood cell : 1.22% ; PBMC-Platelets : 0.60% ; |
|
Hepatitis E virus |
PBMC-T cells : 4.66% ; PBMC-NK : 2.80% ; PBMC-B cells : 2.74% ; PBMC-Red blood cell : 1.19% ; PBMC-Platelets : 0.60% ; |
|
Jaagsiekte sheep retrovirus |
PBMC-Macrophage : 2.99% ; PBMC-Platelets : 0.20% ; PBMC-T cells : 0.11% ; PBMC-Red blood cell : 0.05% ; PBMC-NK : 0.00% ; |
|
Simian sarcoma-associated virus |
PBMC-Macrophage : 2.99% ; PBMC-B cells : 2.05% ; PBMC-Platelets : 0.80% ; PBMC-NK : 0.70% ; PBMC-T cells : 0.68% ; |
|
Murine norovirus |
PBMC-Macrophage : 2.99% ; PBMC-Platelets : 2.39% ; PBMC-B cells : 0.68% ; PBMC-Red blood cell : 0.66% ; PBMC-T cells : 0.46% ; |
|
Rhinovirus C |
PBMC-Macrophage : 1.49% ; PBMC-NK : 1.40% ; PBMC-T cells : 1.25% ; PBMC-Red blood cell : 0.95% ; PBMC-Platelets : 0.80% ; |
|
Encephalomyocarditis virus |
PBMC-Macrophage : 1.49% ; PBMC-Red blood cell : 0.19% ; PBMC-T cells : 0.11% ; PBMC-Neutrophil : 0.00% ; |
|
Suid alphaherpesvirus 1 |
PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.08% ; PBMC-T cells : 0.00% ; |
|
Human alphaherpesvirus 2 |
PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.08% ; PBMC-T cells : 0.00% ; |
|
Bovine alphaherpesvirus 1 |
PBMC-Platelets : 0.40% ; PBMC-Red blood cell : 0.08% ; |
|
Ecotropic murine leukemia virus |
PBMC-Platelets : 0.20% ; PBMC-Red blood cell : 0.07% ; |
|
Coxsackievirus B6 |
PBMC-Red blood cell : 0.09% ; |
|
Human mastadenovirus D |
PBMC-Red blood cell : 0.09% ; PBMC-Neutrophil : 0.00% ; PBMC-Platelets : 0.00% ; PBMC-T cells : 0.00% ; |
|
Coxsackievirus B2 |
PBMC-Red blood cell : 0.09% ; PBMC-Neutrophil : 0.00% ; PBMC-Platelets : 0.00% ; |
|
Human mastadenovirus A |
PBMC-Red blood cell : 0.09% ; |
|
Coxsackievirus B4 |
PBMC-Red blood cell : 0.09% ; |
|
Human mastadenovirus E |
PBMC-Red blood cell : 0.09% ; PBMC-B cells : 0.00% ; PBMC-NK : 0.00% ; PBMC-Macrophage : 0.00% ; |
|
Human mastadenovirus F |
PBMC-Red blood cell : 0.09% ; |
|
SARS coronavirus |
PBMC-Red blood cell : 0.04% ; PBMC-NK : 0.00% ; PBMC-Macrophage : 0.00% ; |
|
Human coronavirus NL63 |
PBMC-Red blood cell : 0.04% ; |